Associated Papers
Association between SLCO1B1 -521T>C and -388A>G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis.
Jiang J et al.
Springerplus, 2016
ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients.
Chen S et al.
Pharmacogenetics and Genomics, 2015
Pharmacogenomics and adverse drug reactions: the case of statins.
Giorgi MA et al.
Expert Opinion on Pharmacotherapy, 2011
UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients.
Onoue M et al.
International Journal of Clinical Oncology, 2009
OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.
Zhang W et al.
Clinical and Experimental Pharmacology & Physiology, 2007
Select a paper to view details